Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2026-01-22 @ 3:52 PM
Study NCT ID:
NCT04035668
Status:
TERMINATED
Last Update Posted:
2023-01-30
First Post:
2019-07-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-08
First Submit QC Date:
None
Study First Post Date:
2019-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-21
Results First Submit QC Date:
None
Results First Post Date:
2022-12-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-08-26
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-01-27
Last Update Post Date:
2023-01-30
Last Update Post Date Type:
ACTUAL